Nimustine
![]() | |
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
N'-[(4-amino-2-methylpyrimidin-5-yl)methyl]-N-(2-chloroethyl)-N-nitrosourea | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Routes of administration | IV |
| Legal status |
|
| Identifiers | |
| CAS Number |
42471-28-3 |
| ATC code | L01AD06 (WHO) |
| PubChem | CID 39214 |
| ChemSpider |
35876 |
| UNII |
0S726V972K |
| KEGG |
D08276 |
| ChEBI |
CHEBI:75270 |
| Chemical data | |
| Formula | C9H13ClN6O2 |
| Molar mass | 272.69 g/mol |
| |
| |
| | |
Nimustine (INN) is a nitrosourea alkylating agent.
| ||||||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.

